MARC2 Antikörper (AA 270-300)

Produktnummer ABIN7873150

Der Kaninchen Polyklonal anti-MARC2 Antikörper (ABIN7873150) detektiert spezifisch MARC2 in WB, IHC (p) und FACS. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für MARC2 Antikörper (AA 270-300) (ABIN7873150)

Target: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MARC2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Produktdetails anti-MARC2 Antikörper

Bindungsspezifität: AA 270-300

Verwendungszweck: Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2

Aufreinigung: Antigen affinity purified

Immunogen: A portion of amino acids 270-300 from the human protein was used as the immunogen for the Mitochondrial amidoxime reducing component 2 antibody.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: The stated application concentrations are suggested starting points. Titration of the Mitochondrial amidoxime reducing component 2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the Mitochondrial amidoxime reducing component 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu MARC2

Target: MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))

Andere Bezeichnung: Mitochondrial amidoxime reducing component 2

Hintergrund: Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.

UniProt: Q969Z3